UBS Global Research predicts quantum advantage could arrive around 2033, where quantum systems outperform classical computers. The report cautions the technology has been described as 'five years away' for two decades, suggesting timelines remain fluid. Analysts extrapolated quantum volume metrics, finding a trajectory similar to Moore's Law.

China leads global public quantum investment with nearly $18 billion, double U.S. public funding. However, the United States dominates private investment at approximately $7 billion. Technical hurdles remain significant; systems require 10 to 100 physical qubits for one error-corrected logical qubit, with trapped ion qubits achieving coherence times up to 600 seconds in labs.

Early economic impact may stem from encryption vulnerabilities, requiring larger keys and slower computation. Under a bullish scenario, 50% of pharmaceutical server capacity could shift to quantum processors by 2035. Companies like IonQ and PsiQuantum are scaling, with PsiQuantum raising over $2 billion targeting commercial systems by 2027.